FSA
EW icon

Financial Sense Advisors’s Edwards Lifesciences EW Stock Holding History

Financial Sense Advisors’s Portfolio EW Stock Details EW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-6,600
Closed -$489K – 119
2024
Q4 		$489K Sell
6,600
-3,300
-33% -$231K 0.16% 78
2024
Q3 		$653K Sell
9,900
-300
-3% -$21.8K 0.18% 77
2024
Q2 		$942K Hold
10,200
– – 0.29% 61
2024
Q1 		$975K Buy
+10,200
New +$857K 0.32% 68
2021
Q3 		– Sell
-18,117
Closed -$1.88M – 109
2021
Q2 		$1.88M Buy
18,117
+846
+5% +$79.7K 0.59% 34
2021
Q1 		$1.45M Buy
17,271
+1,202
+7% +$102K 0.49% 37
2020
Q4 		$1.47M Buy
+16,069
New +$1.33M 0.53% 37

Other funds holding EW

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return

Financial Sense Advisors's EW Position: Q1 2025 in Review

Financial Sense Advisors sold out of Edwards Lifesciences (EW) in Q1 2025, closing a stake of 6,600 shares — an estimated $489K sold.

Financial Sense Advisors first reported a position in EW in Q4 2020 and held it in 7 quarters. The position peaked at $1.88M in Q2 2021. 1,206 funds tracked by Wall St. Rank hold EW as of Q1 2025.

  • Financial Sense Advisors reported no remaining Edwards Lifesciences position as of Q1 2025 after selling out during the quarter.
  • Financial Sense Advisors sold 6,600 Edwards Lifesciences shares in Q1 2025, an estimated $489K.
  • Financial Sense Advisors first reported a position in Edwards Lifesciences in Q4 2020 and held it in 7 quarters.
  • Financial Sense Advisors's Edwards Lifesciences position peaked at $1.88M in Q2 2021.
  • 1,206 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q1 2025.

Based on Financial Sense Advisors's 13F filing for Q1 2025, filed 6 May 2025.